R. Wilson (London, United Kingdom), G. Dimopoulos (Athens, Greece)
Effect of biofilm on induced β-lactamase production in pseudomonas aeruginosa with different genotype
H. Jiang, Z. Li (Qingdao, Jinin, China)
|   |
Community-acquired pneumonia trough enterobacteriaceae and p. aeruginosa: diagnosis, incidence, and predictors. The German CAPNETZ
H. von Baum, T. Welte, R. Marre, N. Suttorp, E. Santiago (Ulm, Hannover, Berlin, Bochum, Germany)
| |
A placebo-controlled study of liposomal amikacin for inhalation nebulized once daily in the treatment of bronchiectasis patients with chronic pseudomonas aeruginosa lung infection
A. O‘Donnell, R. Swarnakar, L. Yashina, P. Nikolova, R. Marinov, P. Waghray, V. Melnik, Z. Lazic, A. Penev, K. Dimakou, M. Mitic-Milikic, I. Kline, G. Tino, D. Bilton, R. Gupta (Monmouth Junction, United States Of America)
| |
Inhaled liposomal ciprofloxacin hydrochloride significantly reduces sputum pseudomonas aeruginosa density in non-CF bronchiectasis
D. Bilton, A. DeSoyza, C. Haworth, P. Bruinenberg, B. Otulana (London, Newcastle, Cambridge, United Kingdom; Hayward, United States Of America)
|  |
Influence of bronchiectasis in COPD exacerbations caused by pseudomonas aeruginosa
M. Sancho, M. Gallego, C. Montón, X. Pomares, D. Mariscal, E. Castañer, A. Marin (Sabadell, Spain)
| |
The S-carboxymethylcysteine reduces the extracellular slime substance of the Pseudomonas aeruginosa biofilm
K. Kishi, S. Otani, A. Iwata, K. Umeki, H. Ishii, R. Shirai, I. Tokimatsu, K. Hiramatsu, J. I. Kadota (Yufu city, Japan)
| |
Pseudomonas aeruginosa and antibiotic resistance in acute exacerbations of COPD (AECOPD)
D. R. Monserrate Mitchell, E. Prats Soro, M. Lopez Sanchez, F. Manresa Presas (Spain)
| |
Neutrophil elastase mediates innate lung protection against Pseudomonas aeruginosa
R. Benabid, T. Hirche, J. Wartelle, N. Guyot, A. Belaaouaj (Reims, France; Frankfurt, Germany)
| |